Jy. Deng et al., SOME CHANGES OF RECEPTOR AND POSTRECEPTOR SIGNAL-TRANSDUCTION REGULATED BY SOMATOSTATIN IN PITUITARY HGH-SECRETING ADENOMAS, Chinese medical journal, 110(9), 1997, pp. 678-681
Objective To investigate the disturbance in the function of SRIF recep
tor, Gi protein and Ca2+ channel in hGH adenoma cells and to evaluate
their significance in the pathogenesis of pituitary hGH adenomas. Meth
ods All 25 patients with pituitary hGH adenoma who were involved in th
is study had typical acromegalic menifestation and high fasting serum
hGH levels of >5.0 mu g/L which were not suppressed to <3.0 mu g/L by
oral glucose tolerence test. The pituitary hGH adenoma tissue obtained
from transphenoidal operation was digested by collagenase and the dis
persed adenoma cells were cultured in the monolayer. The effects of oc
treotide (SMS), a long-acting agonist of somatostatin, on hGH secretio
n and intracellular cAMP level were observed and the influences of per
tussis toxin (PT), an inhibitor of Gi protein, and Ca2+ ionophore A231
87 or KCl on the inhibitory action of octreotide on hGH secretion were
also investigated in the cultured pituitary hGH adenoma cells. Result
s A total of 16.0% (4/25) of cultured pituitary hGH adenomas did not r
espond to octreotide (100 nmol). The inhibitory effect of octreotide o
n hGH secretion was not blocked by PT (50 ng/ml) and A23187 (10 mu mol
) or KCl (22.5 nmol) in 31.6% (6/19) and 35% (7/20) of hGH adenomas, r
espectively. The effects of octreotide on hGH secretion and intracellu
lar cAMP levels mere studied in 10 cultured hGH adenomas. Octreotide s
uppressed both hGH secretion and cAMP levels in 5 cases: inhibited onl
y hGH secretion or the cAMP level in 3 cases and 1 case respectively:
and affected neither hGH secretion nor cAMP level in the last case. Co
nclusion There were abnormalities in the SRIF receptor and/or postrece
ptor signal transduction in 16.0% of hGH adenomas which did not respon
d to octreotide. The defects in Gi and/or Ca2+ channels were found in
52.4% (11/21) of hGH adenomas which had responded to octreotide. These
defects might induce diminution of the inhibitory action of SRIF on h
GH secretion and might be the causes of hypersecretion in some pituita
ry hGH adenomas.